Flexion skyrockets on news of $500M acquisition

The Floridian biotech Pacira BioSciences Inc. is shelling out $500 million to acquire Burlington drugmaker Flexion Therapeutics Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.